celecoxib has been researched along with Hemangiosarcoma in 1 studies
Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to investigate the effects of the COX2 inhibitor celecoxib and the mTOR antagonist rapamycin on angiosarcoma cell lines." | 7.76 | Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines. ( Bundscherer, A; Hafner, C; Köhl, G; Landthaler, M; Vogt, T, 2010) |
| " The aim of this study was to investigate the effects of the COX2 inhibitor celecoxib and the mTOR antagonist rapamycin on angiosarcoma cell lines." | 3.76 | Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines. ( Bundscherer, A; Hafner, C; Köhl, G; Landthaler, M; Vogt, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bundscherer, A | 1 |
| Vogt, T | 1 |
| Köhl, G | 1 |
| Landthaler, M | 1 |
| Hafner, C | 1 |
1 other study available for celecoxib and Hemangiosarcoma
| Article | Year |
|---|---|
Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cel | 2010 |